Covid

Dosing intervals for COVID-19 mRNA Vaccine

Jan 14, 2021 | Beth Hess

On January 6, CDC revised Interim Clinical Considerations for Use of mRNA COVID-19 Vaccines Currently Authorized in the United States. The portion regarding dosing intervals is summarized below:

  • Routine Scheduling. Do not schedule people to receive dose #2 earlier than recommended (i.e., 21 days for Pfizer-BioNTech or 28 days for Moderna).
  • Inadvertent Early Doses. Dose #2 inadvertently administered as much as 4 days too early (“grace period”) should be considered valid.
  • No Maximum Interval. There is no maximum interval between dose #1 and dose #2 for either vaccine. If dose #2 is administered beyond 21 or 28 days, there is no need to restart the series or repeat the dose.
  • Errors. Vaccine administration errors should be reported to the Vaccine Adverse Event Reporting System (VAERS).

Visit CDC’s COVID-19 Vaccination: Clinical Considerations gateway page for more information.


About Beth Hess

More posts by Beth Hess

Related Posts

Website New Episode w Special Guests
  • Press Release Podcast

NACCHO’s Podcast From Washington: New Changes to the WIC...

On this week’s episode: New Changes to WIC Program and Local Health Officer...

Apr 19, 2024

NACCHO’s Podcast From Washington: New Changes to the WIC...

Picture1
  • Community Health Health & Disability

Transformative Health Data Approaches Within the...

CDC is assisting LHDs with technical assistance to improve the quality of data...

Apr 19, 2024 | Jerome Bronson

Transformative Health Data Approaches Within the...

  • Tools & Resources Communications & Public Relations Public Health and Homelessness

NACCHO Social Media Strategy - National Public Health...

National Public Health Week (NPHW) was from April 1 to April 7, 2024.

Apr 11, 2024 | Emma James

NACCHO Social Media Strategy - National Public Health...

  • HIV, STI, & Viral Hepatitis

National Youth HIV/AIDS Awareness Day  Spotlight: St....

 In honor of National Youth HIV/AIDS Awareness Day on April 10th, NACCHO is...

Apr 11, 2024 | Anthony Green

National Youth HIV/AIDS Awareness Day  Spotlight: St....

  • HIV, STI, Viral Hepatitis, and Harm Reduction Digest

Digest (April 10, 2024)

HIV, STI, Viral Hepatitis, and Harm Reduction Digest: April 10. 2024

Apr 11, 2024

Digest (April 10, 2024)

  • HIV, STI, & Viral Hepatitis

National Youth HIV/AIDS Awareness Day Spotlight:...

In honor of National Youth HIV/AIDS Awareness Day on April 10th, NACCHO is...

Apr 10, 2024 | Anthony Green

National Youth HIV/AIDS Awareness Day Spotlight:...

Hands teamwork i Stock 648817898
  • Cardiovascular Health Chronic Disease Social Determinants of Health

Empowering Local Health Departments: A Spotlight on...

PRCs are more than just research institutions; they are catalysts for change at...

Apr 10, 2024 | Johanna Segovia

Empowering Local Health Departments: A Spotlight on...

  • HIV, STI, & Viral Hepatitis

National Youth HIV/AIDS Awareness Day Spotlight: SMYAL

In honor of National Youth HIV/AIDS Awareness Day on April 10th, NACCHO is...

Apr 09, 2024 | Anthony Green

National Youth HIV/AIDS Awareness Day Spotlight: SMYAL

  • Access to Care Chronic Disease Community Health Health & Disability

Navigating the Intersection of Disability and Chronic...

Chronic Disease, Disability, and Aging: Understanding the Connection

Apr 09, 2024 | Jasdeep Dulay

Navigating the Intersection of Disability and Chronic...

Back to Top